Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | THPO | P40225 | 2/20 | 0.39 |
| ▸ | CTH | P32929 | 1/20 | 0.39 |
| ▸ | CBS | P35520 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | PAM | P19021 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL11342939 | 0.88 | FFAR3 (0.44) | TSHRTHPOCTHCBSL3MBTL1 | |
| SCHEMBL568585 | 0.85 | — | — | |
| SCHEMBL8447074 | 0.82 | — | — | |
| SCHEMBL28011582 | 0.82 | — | — | |
| Ethaneperoxoic Acid SCHEMBL1501690 | 0.78 | ALDH1A1 (0.50) | TSHRTHPOALDH1A1LMNAFFAR3 | |
| Ethaneperoxoic Acid SCHEMBL1501687 | 0.78 | — | — | |
| Ethaneperoxoic Acid SCHEMBL912961 | 0.75 | — | — | |
| Ethaneperoxoic Acid SCHEMBL1451487 | 0.75 | ALDH1A1 (0.47) | TSHRTHPOALDH1A1LMNAFFAR3 | |
| Ethaneperoxoic Acid SCHEMBL809506 | 0.75 | ALDH1A1 (0.47) | TSHRTHPOALDH1A1LMNAFFAR3 | |
| Ethaneperoxoic Acid SCHEMBL5675009 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1466897-B1 | Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group in the presence of epsilon-phthalimidoperhexanoic acid | DIPHARMA FRANCIS SRL (IT) | 2008-12-17 | — | — | EP | disclosed |
| EP-1518857-B1 | A process for the preparation of pantoprazole and salts thereof | DIPHARMA FRANCIS SRL (IT) | 2007-08-08 | — | — | EP | disclosed |
| US-7081534-B2 | Process for the preparation of pantoprazole and salts thereof | DIPHARMA S.P.A. (IT) | 2006-07-25 | — | — | US | disclosed |
| US-6998490-B2 | Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group | DINAMITE DIPHARMA S.P.A. (IT) | 2006-02-14 | — | — | US | disclosed |
| US-20050096352-A1 | Process for the preparation of pantoprazole and salts thereof | DIPHARMA S.P.A. (IT) | 2005-05-05 | — | — | US | disclosed |
| EP-1518857-A1 | A process for the preparation of pantoprazole and salts thereof | Dipharma S.p.A. (IT) | 2005-03-30 | — | — | EP | disclosed |
| EP-1466897-A1 | Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group in the presence of epsilon-phthalimidoperhexanoic acid | Dipharma S.p.A. (IT) | 2004-10-13 | — | — | EP | disclosed |
| US-20040192929-A1 | Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group | DINAMITE DIPHARMA S.P.A. ABBREVIATED DIPHARMA S.P.A. | 2004-09-30 | — | — | US | disclosed |
| US-6162394-A | Hygienic agent for use in hemodialysis | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2000-12-19 | — | — | US | disclosed |
| US-5851483-A | Hygienic agent for use in hemodialysis | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1998-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050096352-A1 | Process for the preparation of pantoprazole and salts thereof | PPOX, MLN, PNPO | TSHR 1627/4885THPO 476/4885CTH 2572/4885 |
| US-20040192929-A1 | Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group | STS, MPST, SULT2A1 | TSHR 782/4885THPO 279/4885CTH 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.